BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 15 filers reported holding BIOMX INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,219 | -50.2% | 23,350 | -49.1% | 0.00% | – |
| Q2 2023 | $16,506 | +164960.0% | 45,850 | +37.8% | 0.00% | – |
| Q1 2023 | $10 | -80.4% | 33,266 | -87.7% | 0.00% | – |
| Q4 2022 | $51 | -99.8% | 270,848 | +208.6% | 0.00% | – |
| Q3 2022 | $30,000 | -48.3% | 87,757 | +11.2% | 0.00% | – |
| Q2 2022 | $58,000 | -69.1% | 78,933 | -18.9% | 0.00% | – |
| Q1 2022 | $188,000 | -27.1% | 97,355 | -39.6% | 0.00% | – |
| Q4 2021 | $258,000 | -71.4% | 161,114 | -45.4% | 0.00% | -100.0% |
| Q3 2021 | $903,000 | -61.3% | 295,175 | -31.0% | 0.00% | 0.0% |
| Q2 2021 | $2,335,000 | -27.8% | 427,702 | -5.9% | 0.00% | -50.0% |
| Q1 2021 | $3,235,000 | +10.2% | 454,377 | -1.2% | 0.00% | 0.0% |
| Q4 2020 | $2,935,000 | +11.5% | 460,047 | +10.8% | 0.00% | -33.3% |
| Q3 2020 | $2,633,000 | +61.3% | 415,296 | +40.5% | 0.00% | +50.0% |
| Q2 2020 | $1,632,000 | +54.4% | 295,615 | +95.8% | 0.00% | 0.0% |
| Q1 2020 | $1,057,000 | – | 150,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,133,402 | $3,413,000 | 0.39% |
| MMCAP International Inc. SPC | 684,451 | $1,095,000 | 0.07% |
| Kepos Capital LP | 450,597 | $721,000 | 0.06% |
| Orbimed Advisors | 2,813,489 | $4,502,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 98,700 | $158,000 | 0.00% |
| ROYCE & ASSOCIATES LP | 106,696 | $171,000 | 0.00% |
| J. Goldman & Co LP | 150,000 | $15,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31,106 | $50,000 | 0.00% |
| Renaissance Technologies | 76,300 | $122,000 | 0.00% |
| UBS Group AG | 7,217 | $12,000 | 0.00% |